| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...739373S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0039373 |
| P932 | PMC publication ID | 3412849 |
| P698 | PubMed publication ID | 22879874 |
| P5875 | ResearchGate publication ID | 230645913 |
| P50 | author | Jason Kindrachuk | Q47036869 |
| Robert E. W. Hancock | Q53441913 | ||
| Tobias Hirsch | Q115686178 | ||
| Ingo Stricker | Q115686185 | ||
| Lars Steinstraesser | Q115704122 | ||
| Frank Jacobsen | Q115704133 | ||
| P2093 | author name string | Jason Kindrachuk | |
| Evgenija A Mersch | |||
| Havard Jenssen | |||
| Matthias Schulte | |||
| Maximilian Kueckelhaus | |||
| Nicole Afacan | |||
| P2860 | cites work | LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells | Q24675869 |
| Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis | Q28303994 | ||
| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies | Q29617810 | ||
| Cutaneous wound healing | Q29618894 | ||
| Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities | Q33213044 | ||
| Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment | Q33526956 | ||
| Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds | Q34326463 | ||
| Cellular and molecular basis of wound healing in diabetes | Q34625159 | ||
| Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? | Q35010044 | ||
| Biology and clinical relevance of naturally occurring antimicrobial peptides | Q35016434 | ||
| Host defense peptides in burns | Q35913694 | ||
| Impact of LL-37 on anti-infective immunity. | Q35966461 | ||
| Host defense peptides and the new line of defence against multiresistant infections | Q37108625 | ||
| Host defense peptides in wound healing. | Q37127271 | ||
| Host defense peptides for use as potential therapeutics. | Q37386742 | ||
| PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox | Q37568472 | ||
| Potential of immunomodulatory host defense peptides as novel anti-infectives | Q37580524 | ||
| In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. | Q38298534 | ||
| Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity | Q39867194 | ||
| The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. | Q40609292 | ||
| The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses | Q40702297 | ||
| Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes | Q40991506 | ||
| Diabetes-obesity syndromes in mice | Q41463282 | ||
| Sequence and specificity of two antibacterial proteins involved in insect immunity | Q42077306 | ||
| Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus | Q43566314 | ||
| A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis | Q43969583 | ||
| A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release | Q44832287 | ||
| Structural studies of a peptide with immune modulating and direct antimicrobial activity | Q45581908 | ||
| HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair | Q46162282 | ||
| The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor | Q46738082 | ||
| An anti-infective peptide that selectively modulates the innate immune response | Q50072960 | ||
| Activity of histone H1.2 in infected burn wounds. | Q50771799 | ||
| The human host defense peptide LL37/hCAP accelerates angiogenesis in PEGT/PBT biopolymers. | Q51299820 | ||
| Human beta-defensin-3 promotes wound healing in infected diabetic wounds | Q56990633 | ||
| The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium | Q73043045 | ||
| PR39, a peptide regulator of angiogenesis | Q73308219 | ||
| Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37 | Q74129095 | ||
| Effects of human neutrophil peptide-1 on the expression of interstitial collagenase and type I collagen in human dermal fibroblasts | Q74446533 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | wound healing | Q1509074 |
| P304 | page(s) | e39373 | |
| P577 | publication date | 2012-08-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Innate defense regulator peptide 1018 in wound healing and wound infection | |
| P478 | volume | 7 |
| Q28488709 | Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models |
| Q39011788 | An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model |
| Q34447679 | Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens. |
| Q52592947 | Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds. |
| Q47375349 | Antimicrobial Peptides: An Introduction |
| Q89273364 | Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo |
| Q34507671 | Antimicrobial peptides and wound healing: biological and therapeutic considerations |
| Q36183973 | Cationic bactericidal peptide 1018 does not specifically target the stringent response alarmone (p)ppGpp |
| Q41577433 | Clavanin A improves outcome of complications from different bacterial infections |
| Q38967477 | Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses. |
| Q36090102 | High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides |
| Q38162670 | Immune modulation by multifaceted cationic host defense (antimicrobial) peptides |
| Q35912382 | Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration |
| Q52691351 | In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design. |
| Q60914154 | In vitro and in vivo properties of the bovine antimicrobial peptide, Bactenecin 5 |
| Q48219322 | Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways |
| Q35163990 | Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model |
| Q33731274 | Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound |
| Q34058299 | LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents |
| Q49996616 | Mechanism of Hbγ-35-induced an increase in the activation of the human immune system by endotoxins |
| Q34769341 | Novel biodegradable porous scaffold applied to skin regeneration. |
| Q42014234 | Peptide IDR-1002 Inhibits NF-κB Nuclear Translocation by Inhibition of IκBα Degradation and Activates p38/ERK1/2-MSK1-Dependent CREB Phosphorylation in Macrophages Stimulated with Lipopolysaccharide |
| Q38263995 | Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections |
| Q37598400 | Peptide design for antimicrobial and immunomodulatory applications |
| Q33700825 | Perspectives for clinical use of engineered human host defense antimicrobial peptides |
| Q40594176 | Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice. |
| Q26765450 | Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides |
| Q37696015 | Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing |
| Q91559076 | Supreme activity of gramicidin S against resistant, persistent and biofilm cells of staphylococci and enterococci |
| Q34544517 | Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation |
| Q47118800 | Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection |
| Q95840995 | The Antimicrobial Peptide Human Beta-Defensin 2 Inhibits Biofilm Production of Pseudomonas aeruginosa Without Compromising Metabolic Activity |
| Q28548287 | The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing? |
| Q50214791 | The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus |
| Q35992127 | The immunology of host defence peptides: beyond antimicrobial activity |
| Q42205540 | The specificity of protection against cationic antimicrobial peptides by lactoferrin binding protein B. |
| Q38401924 | Therapeutic utility of antibacterial peptides in wound healing |
| Q48198173 | Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model. |
| Q28546464 | Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide |
| Q42672939 | Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial |
| Q57292032 | Wound healing in wild male baboons: Estimating healing time from wound size |
| Q48149164 | Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries |
Search more.